期刊
ORGANOMETALLICS
卷 35, 期 7, 页码 1008-1014出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.organomet.6b00059
关键词
-
资金
- NIH-NIGMS [GM088237]
- NIH-NIBIB [EB013042]
- Blavatnik Biomedical Accelerator
- DOE BER [DE-SC0001249]
- Harvard/MGH Nuclear Medicine Training Program from the Department of Energy [DE-SC0008430]
- National Center for Research Resources [1S10RR017208-01A1]
- DOE SCGF
Translation of new F-18-fluorination reactions to produce radiotracers for human positron emission tomography (PET) imaging is rare because the chemistry must have useful scope and the process for F-18-labeled tracer production must be robust and simple to execute. The application of transition metal mediators has enabled impactful F-18-fluorination methods, but to date none of these reactions have been applied to produce a human-injectable PET tracer. In this article we present chemistry and process innovations that culminate in the first production from [F-18]fluoride of human doses of [F-18]5-fluorouracil, a PET tracer for cancer imaging in humans. The first preparation of nickel 6-aryl complexes by transmetalation from arylboronic acids or esters was developed and enabled the synthesis of the [F-18]5-fluorouracil precursor. Routine production of >10 mCi doses of [F-18]5-fluorouracil was accomplished with a new instrument for azeotrope-free [F-18]fluoride concentration in a process that leverages the tolerance of water in nickel-mediated F-18-fluorination.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据